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Abstract
Background: hTERT/cdk4 immortalized myogenic human cell lines represent an important tool for skeletal muscle
research, being used as therapeutically pertinent models of various neuromuscular disorders and in numerous
fundamental studies of muscle cell function. However, the cell cycle is linked to other cellular processes such as
integrin regulation, the PI3K/Akt pathway, and microtubule stability, raising the question as to whether genetic
modification related to the cell cycle results in secondary effects that could undermine the validity of these cell models.
Results: Here we subjected five healthy and disease muscle cell isolates to transcriptomic analysis, comparing
immortalized lines with their parent primary populations in both differentiated and undifferentiated states, and testing
their myogenic character by comparison with non-myogenic (CD56-negative) cells. Principal component analysis of
global gene expression showed tight clustering of immortalized myoblasts to their parent primary populations, with
clean separation from the non-myogenic reference. Comparison was made to publicly available transcriptomic data
from studies of muscle human pathology, cell, and animal models, including to derive a consensus set of genes
previously shown to have altered regulation during myoblast differentiation. Hierarchical clustering of samples based
on gene expression of this consensus set showed that immortalized lines retained the myogenic expression patterns of
their parent primary populations. Of 2784 canonical pathways and gene ontology terms tested by gene set enrichment
analysis, none were significantly enriched in immortalized compared to primary cell populations. We observed, at the
whole transcriptome level, a strong signature of cell cycle shutdown associated with senescence in one primary
myoblast population, whereas its immortalized clone was protected.
Conclusions: Immortalization had no observed effect on the myogenic cascade or on any other cellular processes,
and it was protective against the systems level effects of senescence that are observed at higher division counts of
primary cells.
Background
Research on neuromuscular disorders, including poten-
tial therapeutic options, depends on the careful observa-
tion of clinical symptoms and of biopsy material from
human subjects, and also on the availability of disease
models that both accurately reflect aspects of the
pathology and facilitate experimental intervention. Ani-
mal models allow the experimental manipulation of fully
vascularized, innervated muscle tissue, and they often
recapitulate to a large extent the complexity of interac-
tions between human cell and tissue types, and how
those interactions change in disease and development.
In contrast, the relative homogeneity of isolated and
purified cell lines has a double-edged significance: it
renders them pertinent only to certain aspects of certain
pathologies, but it also facilitates the close study of
specific molecular mechanistic events. In addition, where
they are understood to closely recapitulate some meas-
urable aspect of the pathology, cell models can be highly
amenable to high-throughput studies.
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From a systems biology perspective, compared with
whole organisms, cell lines more closely (however im-
perfectly) represent a single enclosed apparatus in which
changes to one or more component(s) have direct mech-
anistic impact on connected components. This is par-
ticularly true of pathologic muscle, in which processes
such as regeneration, inflammation, fibrosis, and adipo-
genesis all conspire to a general loss of order and in-
crease in tissue heterogeneity. These changes in whole
muscle composition can be observed in transcriptomes
and other omics profiles, and may obscure underlying
mechanistic details. However, isolated primary myoblasts
suffer the disadvantage that they undergo senescence
with amplification in tissue culture. Immortalization
avoids senescence and thereby facilitates subsequent
cloning to select a highly pure model cell line.
Adult human primary myoblasts senesce after approxi-
mately 25 rounds of division in tissue culture due to cell
cycle suppression by the p16Ink4a-dependent stress path-
way and progressive telomere shortening which triggers
cell cycle exit mediated by activation of p53 [1–3]. We
showed that immortalization of human myoblasts re-
quires bypassing of both of these senescence mecha-
nisms, and we achieved this by transduction of the
murine cyclin-dependent kinase (cdk)-4, which over-
comes the p16 pathway, and of human telomerase re-
verse transcriptase (hTERT) which preserves telomere
length [4].
Using this method, we have created a large collection
of immortalized human myoblasts isolated from a wide
range of neuromuscular disorders. Several have been val-
idated as experimental models for Duchenne muscular
dystrophy (DMD) [5–8], limb girdle muscular dystrophy
type 2B (LGMD-2B) [9], facioscapulohumeral muscular
dystrophy (FSHD)—including mosaic-origin control
lines from the same patient [10–12], and excitation-
contraction coupling and calcium homeostasis [13].
These cell lines have contributed to the development
of therapeutic approaches such as oligonucleotide-
mediated exon skipping [5], read-through of non-sense
mutations [6], and gene correction [7, 8] for DMD, to
the study of ryanodine receptor 1 (RyR1) deficiency in
congenital myopathies [14], cell senescence in myotonic
dystrophy type I [15], the involvement of IL-6 and Akt
in the pathogenesis of myasthenia gravis [16], the
dysregulation of DUX4c [11] and the role of FAT1 [12]
in FSHD, and the shutdown of quiescence pathways in
ageing [17]. They have also been used to explore funda-
mental aspects of muscle cell physiology including: the
role of β-arrestins in myogenesis [18], the role of MMP-
14 in human myoblast collagen invasion [19], nuclear
protein spreading between nearby myonuclei [20], the
effects of oxidative stress on myoblast calcium-
dependent proteolysis [21] and the proteome [22],
engineering of 3D micro-muscles [23], and the function
of miRNAs during myoblast differentiation [24], this list
being non-exhaustive. Thus, they have become an im-
portant resource to the muscle research community.
To validate the use of immortalized myoblasts, we pre-
viously confirmed the expression of myogenic markers
MyoD, NCAM, desmin, and various myosin isoforms, in
differentiated myotubes, the morphology of myotubes by
immunostaining of sarcomeric myosin, and their cap-
acity to contribute to myofibre formation in vivo [4, 25].
A separate validation was carried out on two lines of
healthy and four of dysferlin-deficient (LGMD-2B)
immortalized clones: relative to their parent primary
populations, they showed unaltered expression of
myogenic markers MHC, alpha-tubulin, desmin, and
caveolin-3, unaltered sarcomere formation and subcellu-
lar localization on immunofluorescence imaging of these
same markers, and unaltered membrane repair processes
[9]. In a third study, the physical properties of Ca2+ re-
lease and its response to pharmacological intervention
were unaltered in immortalized lines compared with pri-
maries [13].
However, the cell cycle is a major pathway that is
linked to other cellular processes, including integrins
[26], the PI3K/Akt pathway [27], apoptosis [28], and
microtubule stability [29], each of which may be import-
ant to muscle cell function and pathology. Perturbations
to the cell cycle may impact on these and on other less
directly associated processes. Furthermore, it is increas-
ingly understood that cyclin-dependent kinases are im-
plicated in roles beyond the cell cycle, including aspects
of transcription, metabolism, and stem cell self-renewal
(reviewed [30]). Despite the wide use of our cdk4/hTERT
immortalized human myoblasts, the potential secondary
effects of immortalization have been tested only for
those parameters listed above, relating to myogenesis
and the functioning of membrane repair and calcium
homeostasis. Secondary effects of cdk4/hTERT transduc-
tion on other processes that have not yet been tested
would challenge the usefulness of these immortalized
lines as experimental models and could undermine
previous and ongoing studies that use these cell lines.
A second risk to the representativeness of these cell
models occurs when we select a clonal line from the im-
mortalized population: despite that the purity of our pri-
mary cell isolates is monitored by immunostaining
against the myogenic marker desmin, the immortalized
population may still exhibit cell-to-cell variability, so that
any given clone may represent only part of its parent
primary population. A third risk is that, relative to
primary populations, immortalized clonal lines that
undergo long-term experimental use are repetitively
amplified and maintained for prolonged periods in tissue
culture conditions, whereas time in tissue culture has
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been associated to loss of myogenic potential [31–33].
Thus, it is important to determine whether immortalized
clonal myogenic lines diverge from their mortal parent
primary populations.
Here we use extensive transcriptomic profiling of
cdk4/hTERT immortalized human myoblasts in their
undifferentiated and differentiated states, comparing
them with their mortal parent populations, and with a
non-myogenic reference population. In this way, we ob-
tain a systems level view of cellular processes, allowing
us to determine whether secondary effects are incurred
by cdk4/hTERT immortalization.
Results
Immortalized clonal lines retain the system profile of
their primary parent population
We generated microarray gene expression profiles for 94
samples comprising primary myoblasts and their corre-
sponding immortalized clones in both differentiated and
undifferentiated states (average of 4 cell culture repli-
cates each) from 5 human subjects (Table 1; 2 healthy
and 3 with Duchenne muscular dystrophy—DMD), to-
gether with primary populations of non-myogenic
(CD56-ve) cells from the muscles of 8 other human sub-
jects. Prior to analysis, each of the populations was
sorted for CD56 using magnetic beads and confirmed to
be >94% desmin-positive for myogenic cells (Fig. 1) or
100% desmin-negative for the CD56-ve populations. To
maximize the maturity and the expression levels of late
myogenic markers, myotubes were maintained for 9 days
in differentiation conditions, at which time no notable
cell death or detachment had occurred.
Data complexity reduction using principal component
analysis (PCA) showed that samples clustered into three
groups: myoblasts and myotubes were separated from
each other across principal components 1 and 2,
whereas the CD56-negative population was separated
from the others by principal component 3 (Fig. 2). An
overall view of the three groups, with primaries and
clones indicated, is presented (Fig. 2a), and the same
data are shown again for myoblasts (Fig. 2b) and
myotubes (Fig. 2c) alone (for comparison, CD56-neg are
included in each case). Replicate culture dishes clustered
tightly. Importantly, immortalized clones clustered
closely to their parent primary populations, and data-
points representing clones were not shifted in any
particular direction relative to their parent primary
population. Among the myoblasts, the primary C25
population was an outlier, clustering separately from the
other myoblast populations (including from its own
immortalized clonal line)—this primary population is
analyzed and discussed further below.
Differentiation of immortalized clonal lines follows the
normal myogenic cascade
To study the behavior of genes involved in the myogenic
cascade in immortalized and primary cell lines, we cre-
ated a consensus set of genes that were differentially
expressed in four previously published studies of myo-
blast differentiation (Additional file 1: Table S1). These
studies included human and mouse primary myoblasts,
and C2C12 myoblasts, and we retained genes that were
strongly up or downregulated after five or more days of
differentiation in at least three of the four datasets. For
the consensus downregulated genes, a heatmap showing
their relative expression levels across our samples is
shown: note the rows near the top of the figure that in-
dicate the cell_type and clonal_state (Fig. 3). Hierarchical
clustering analysis of the samples is presented on the
same plot (branch lines at top of figure) and shows that
these genes neatly separated myoblasts (cyan in the
cell_type row) from myotubes (lilac in the cell_type row)
with no effect of immortalization (green and yellow in
the clonal_state row)—myoblast clones showed similar
expression values to the myoblast primary populations,
and myotube clones showed similar expression values to
the myotube primary populations.
Differentiation induced consistent downregulation
in both primaries and immortalized clones of
genes involved in cell cycle regulation and DNA
replication, such as centromere components (CENPA,
CENPK), mini-chromosome maintenance (MCM3),
DNA topoisomerases (TOP2A), regulation of mitotic
spindle formation (CDCA8), G2/mitotic-specific cyclin-B2
(CCNB2), and the MyoD regulator ID2 [34]. Genes such as
cyclin-dependent kinase 1 (CDK1) and cyclin dependent
Table 1 Cell populations used, with their origins and division counts
Cell line Phenotype Mutation Age of subject Sex of subject Muscle of origin Division countsa (prim./immort.)
CHQ Healthy – 5.5 days Female Quadriceps 29/83
C25 Healthy – 25 years Male Semitendinosus 16/86
DMD6594 Duchenne MD Del 48–50 20 months Male Quadriceps 7.5/51
DMD6311 Duchenne MD Del 45–52 23 months Male Quadriceps 10/50
DMD8036 Duchenne MD Del 48–50 6 years Male Biceps 8.5/46
aNumber of divisions undergone by primary and immortalized clonal cells at the time of harvesting for transcriptomic analysis
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kinase regulators (e.g., CKS1B) were downregulated nor-
mally in clonal lines despite the presence of the murine
cdk4 transgene.
For the consensus upregulated genes, a similar
heatmap is shown (Fig. 4). Similarly to the consensus
downregulated genes, immortalization had no effect on
the upregulation of the myogenic regulator MEF2C,
metabolic genes such as creatine kinase (CKM) and
ATPase 1A2 (ATP1A2), nor on contractile components
and their regulators, including alpha-actinin (ACTN2),
calpain-3 (CAPN3), myosins and their partners (MYBPH,
MYL2, MYL4, MYLPF, MYH1, MYH3, MYH7, MYH8),
troponins (TNNC1, TNNC2, TNNI1, TNNI2, TNNT1,
TNNT3), myomesins (MYOM1, MYOM2), myozenin 2
(MYOZ2), and titin (TTN). Markers of mature myotube
formation such as the dihydropyridine receptor calcium
channel (CACNA1S), and the RYR1, were also unaffected
by immortalization.
There were few exceptions to the clustering of
myoblasts separately from myotubes. The myotubes
(both primary and immortalized) of one subject
(DMD8036) showed stronger upregulation of myogenic
genes and clustered separately from the other myotubes.
The outlier myoblast primary line (C25) clustered with
myotubes in the heatmap for downregulation, suggesting
that this line had shutdown its cell cycle. The myotubes
of two lines (DMD6311 clones and DMD 6594 primar-
ies), despite strong downregulation of the cell cycle,
showed relatively weak upregulation of the myogenic
cascade and clustered with myoblasts in the upregulated
heatmap. As a general rule, the normal myogenic cas-
cade was maintained in immortalized clonal lines.
Immortalization has no effect on other systems processes
and has no effects that are similar to previously reported
perturbations of muscle cells
We used rank-based gene set enrichment (GSEA) of
2784 canonical pathways and gene ontology terms to
test for effects of immortalization on systems processes,
separately in myoblasts and myotubes. Immortalized
clones of neither myoblasts nor myotubes showed any
significantly enriched rank distributions with FDR q
values < 0.05 for any of the canonical pathways and gene
ontology terms. Since we expected the cdk4 transgene to
elicit changes to cell cycle regulation in myoblasts, we
specifically checked rank distribution patterns for related
gene sets. Of 22 cell cycle-related gene sets, none were
significant (all had FDR q values > 0.2), but 6 had nom-
inal p values < 0.05 (a measure that does not adjust for
gene set size or multiple hypothesis testing). As these
can be considered borderline significant, we include a
heatmap (Additional file 1: Figure S1) showing the ex-
pression levels of genes that are driving this effect (de-
fined by the overlap of GSEA leading edges). These
genes generally showed some upregulation in immortal-
ized myoblast clones relative to primary myoblasts, but
with the C25 primary outlier showing relatively very
strong dysregulation (most genes were downregulated in
C25 relative to all of the other lines and a few were
upregulated).
To test for effects on gene expression that were similar
to previously reported perturbations of muscle cells, we
applied GSEA to muscle gene sets (http://sys-myo.
rhcloud.com/muscle_gene_sets.php). These gene sets
were comprised of 393 lists of genes that were up- or
downregulated in a large variety of genetic and experi-
mental comparisons in published muscle microarray
studies, mainly of human or murine tissue and cell samples.
These lists were obtained from more than 100 studies, and
included the 4 in vitro differentiation datasets from which
our consensus set was derived as described above. When
immortalized clones of myoblasts or myotubes were
compared to their respective primary cells, neither
showed any significantly enriched rank distributions with
Fig. 1 Representative images of primary and immortalized human
myotubes. Myogenic cells were purified by magnetic bead sorting
of CD56 expression then differentiated for 5 days. Examples here are
from primary (a) and immortalized (b) populations of a healthy
subject (CHQ). Myotubes were immunostained for desmin (green) to
determine the percentage of myogenic purity (>94% for all
samples). Magnified region shows the structure of desmin
filaments in both primary and immortalized cells. Nuclei are
DAPI-stained (blue). Scale = 100 μm
Thorley et al. Skeletal Muscle  (2016) 6:43 Page 4 of 12
FDR q val < 0.05 for any of the 393 muscle gene sets.
Muscle gene sets represent an ensemble of genes that are
identified empirically to respond at the expression level to
muscle perturbations, so their lack of change in immortal-
ized v primary cells is indicative that immortalization has
little effect on these lines. For instance, it is informative to
contrast those results with the following: when genes of
our dataset were ranked according to their change in
myotubes v myoblasts, GSEA on the muscle gene sets
specifically identified strong overlap with 35 of the 393
muscle gene sets with a very highly stringent statistical
cut-off of FDR < 0.001: these highly significant muscle
gene sets are visualized using an enrichment map—this
shows gene sets that were downregulated (in myotubes v
myoblasts) in blue with color intensity proportional to the
enrichment score (none of these highly significant gene
sets were upregulated in this case), and grey connections
represent the sharing of genes between gene sets (i.e.,
some gene sets are similar to each other) (Additional file
1: Figure S2). This analysis shows the strong similarity of
previously published muscle differentiation gene expres-
sion changes with differentiation-induced changes in the
present study when myotubes are compared to myo-
blasts—whereas the comparison of immortalized with pri-
mary cells, in contrast, did not induce changes that were
similar to any previously published data.
Rank-based gene set enrichment testing of canonical
pathways, gene ontology, and previous muscle studies,
were all consistent with hTERT/cdk4 immortalization
having a minimal effect on the systems characteristics of
human myoblasts.
In addition, we tested for specific effects of immortalization
on other pathways previously observed to be influenced by
the cell cycle. We found no change in the levels of specific
phosphorylated proteins involved in the regulation of
Akt pathway activity (Additional file 1: Figure S3) or
Fig. 2 Principal component analysis of gene expression data from
primary cells and immortalized clones of human myoblasts and
differentiated myotubes, and from primary non-myogenic (CD56-
negative) muscle-resident cells. a Immortalized myoblasts (light
green) cluster together with primary myoblasts (dark green) and
immortalized myotubes (light red) together with primary myotubes
(dark red). Both are separated from non-myogenic cells (cyan).
Data-points are projected onto principal components 1, 2, and 3.
b and c The same data for myoblasts (b) and myotubes (c) alone,
projected onto principal components 1 and 2. For myoblasts, PC1
accounted for 43% and PC2 for 17% of the total variance in the data.
For myotubes, PC1 accounted for 32% and PC2 for 22% of total
variance. Each population is labelled and colored separately according
to the key presented in (b)—immortalized clone populations are
colored a darker shade than their respective primaries. Each
immortalized clone clustered near to its parent primary population,
and clones were not shifted in any particular direction relative to their
parent primary population. Each data-point corresponds to a separate
culture dish (average n = 4 dishes per cell line)
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in the expression of genes involved in microtubule
stability (Additional file 1: Figure S4), and heatmaps
of relative gene expression levels for gene ontology
terms relating to these processes show no clustering
of primary samples separately from immortalized lines
(Additional file 1: Figures S5, S6 and S7).
Downregulation of the cell cycle is the main effect that
distinguishes the C25 primary myoblasts as outliers
Unlike their immortalized clones, primary myoblasts
of the C25 lineage clustered more closely to myotubes
than to other myoblasts (Fig. 2). These cells showed
shutdown of cell cycle genes relative to myoblasts
(Fig. 3), but none of the upregulation of contractile
components observed in myotubes (Fig. 4). Differen-
tial expression analysis and over-representation tests
showed that these processes represented the
strongest differences of C25 primary myoblasts with
other myoblasts and with myotubes (Additional file
1: Figure S8). Our interpretation of these data relate
to our previous observations that human primary
myoblasts senesce in tissue culture [17, 25, 35]. At
the time of harvesting for analysis, which was at 16
cell divisions for the C25 primary line, our transcrip-
tomic data strongly indicate cell cycle shutdown for
this line. This coincides with proliferative arrest,
since our previously published analyses [25] indicate
that the rate of mean population doubling for the
C25 primary population begins to slow after 10–15
divisions, indicative of slowing of the cell cycle as
the population begins to senesce. This did not occur
in any of the immortalized lines, thus immortalization
is protective from senescent shutdown of the
cell cycle.
Fig. 3 Heatmap showing the expression levels in immortalized and primary myogenic human lines of genes that are consistently and strongly
downregulated in a panel of previous studies of myoblast differentiation. A gene is shown if it was among the 300 most strongly downregulated
after five or more days of differentiation in at least three of four studies of human and mouse primary myoblasts, and C2C12 myoblasts.
Expression values are row scaled (i.e., changes are relative across each row for ease of interpretation). Hierarchical clustering analysis of
the cell lines, indicated by branches at top, places myotube lines (indicated in lilac in the cell_type bar at top) separately from myoblasts
(cyan cell_type), except for the C25 primary cells (green cell_type). The non-myogenic population (orange cell_type) clusters with the
myotubes. Immortalized clones (green clonal_state) show the same switch from myoblast to myotube as their parent primary populations
(yellow clonal_state). Hierarchical clustering analysis was also applied to genes (branches to left)
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Discussion
Immortalization does not confer any general dysregula-
tion of normal myogenic processes, nor of any canonical
pathways or gene ontology terms. While senescence
shuts down the cell cycle of primary human myogenic
isolates after a number of divisions in tissue culture,
hTERT/cdk4 immortalized lines are protected, retaining
the characteristics of non-senescent primary lines. In-
deed, the single outlier group in our dataset was a popu-
lation of primary myoblasts—whereas immortalized
clones derived from that primary population remained
similar to the other myoblast lines.
In the search for therapeutic strategies, it is important to
have models that are representative of the in vivo nature of
a pathology but that also allow close dissection of the
mechanistic details of the pathology. When care is taken to
understand the differences between humans and animal
models [36], these models can be used to gain insight into
the full complexity of the human condition such as in the
cross-talk between cell and tissue types, and the relation-
ship of disease progression to developmental changes and
age. Even as advances are made in the modeling of artificial
muscle tissue [23], animal models remain our only possibil-
ity to observe the effects of experimental perturbations on
normally vascularized and innervated muscle tissue. How-
ever, whole muscle tissue samples are not homogenous,
instead consisting of a mix of constituents including myofi-
bers, satellite cells, extracellular matrix, vascular and nerve
tissue, interstitial deposits of fibrous and fatty material,
fibroblasts, fibro/adipogenic (FAP) cells, and immune cells.
When transcriptomic profiles are derived from whole
muscle of patients and animal models, it is impossible to
separate minor gene dysregulation in myonuclei (represent-
ing the bulk of the tissue) from large expression changes in
a lesser component of the tissue. For instance, if immune
genes are upregulated this may reflect a response of the
Fig. 4 Heatmap showing the expression levels in immortalized and primary myogenic human lines of genes that are consistently and strongly
upregulated in a panel of previous studies of myoblast differentiation. A gene is shown if it was among the 300 most strongly upregulated after
five or more days of differentiation in at least three of four studies of human and mouse primary myoblasts, and C2C12 myoblasts. Expression
values are row scaled. Hierarchical clustering analysis of the cell lines and genes are indicated by branches at top and left, respectively. Cell type
and differentiation state are indicated by the cell_type bar at top. Immortalized clones, primary myogenic cells, and non-myogenic cells are indicated
by the clonal_state bar at top
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myofibres themselves and/or an increased infiltration of
immune cells. At worst, as much can be told from the
whole muscle transcriptome as can be guessed from sim-
ple microscopy of a stained muscle section. In these cases,
the transcriptome becomes just another measure of dis-
ease progression, because any insight into the underlying
molecular mechanisms is hidden by changes in tissue
composition. Laser capture microscopy can be applied to
obtain pure tissue from muscle sections [37, 38], but it is
highly laborious to obtain sufficient material by this method
and it is rarely used.
Cell models cannot represent the more complex whole
organism interactions described above, which is why a
full understanding of a pathology will likely require
multiple types of model. However, from the systems
biology perspective, isolated cells can represent a
relatively homogenous sample type so that changes in
the transcriptome or in other omics profiles can be
assumed to reflect changes in the mechanistically linked
components of a single cellular system. So long as it is
understood that an omics profile reflects an averaging
across the population of harvested cells (except if single
cell methods are applied), this assumption can be
applied to carefully purified cell subpopulations such as
the desmin-positive primary myoblast lines used in our
study. To remain as close as possible to the human path-
ology (e.g., for the purpose of assessing therapeutic strat-
egies), ideally human cell isolates are used. However,
adult human myoblasts quickly senesce during in vitro
culture [2–4, 35]. Our recent work underlines the grave
importance of this in the interpretation of experimental
data [17]. Immortalized lines require genetic interference
with the cell cycle, but we developed these lines in order
to have an inexhaustible source of cell model material,
and we have continued in their use because we did not
observe morphological or other obvious abnormalities,
and because of pressing needs in therapeutic develop-
ment. However, question-marks had remained as to
whether immortalization has knock-on effects on other
cellular processes that would overwhelm their natural
biological variation and thus challenge their usefulness
as experimental models. The results presented here
show that immortalized cells retain gene expression
patterns that are characteristic of their cell type, as
distinct from the non-selected (CD56-ve) fraction, and
whether as undifferentiated myoblasts or as differenti-
ated myotubes. Furthermore, immortalized cells gener-
ally remain very close in expression profile to their
parent primary populations: the exception that we
observed was linked to loss of normal profile in the
primary cells rather than the immortalized cells. Thus,
immortalization is protective of the characteristics of the
primary population against the effects of senescence in
cell culture.
A second concern was that we typically select clonal
lines from within each immortalized population on the
basis of their capacity to form morphologically well-
defined myotubes, visualized by desmin immunostain-
ing, thus selecting just one cell subtype from among the
variation that was present in the original primary popu-
lation. Our data would suggest that this does not lead to
any systematic biases. Differentiated clones did not show
any systematic over-expression of myogenic and muscle
contractile genes relative to primary cells (Fig. 4).
Conclusions
Immortalization using hTERT and cdk4 transgenes pre-
serves and protects the natural biological variation of
desmin-purified human primary myoblasts. Clones iso-
lated from immortalized primaries are representative of
their parent primary population and represent valuable
research tools for the study of human neuromuscular
disease.
Methods
Cell lines and media
Myogenic primaries and clonal lines of two healthy
(CHQ and C25 and three DMD (DMD 6311, DMD
6594, and DMD 8036) subjects and CD56-negative cell
lines (AB424, AB431, AB439, AB440, AB423, AB425,
AB429, and AB451) of eight healthy subjects were
cultured in proliferation medium (1 volume of M199,
4 volumes of Dulbecco’s modified Eagle’s medium
(DMEM), 20% foetal bovine serum (Invitrogen), 50 μg/mL
gentamicin (Invitrogen), 25 μg/mL fetuin, 0.5 ng/mL bFGF,
5 ng/mL EGF, 0.2 μg/mL dexamethasone, 5 μg/mL insulin)
on matrigel-covered petri dishes (0.1 mg/mL, 1 mL per
19.5 cm2 dish area, 45 min, 37 °C), incubated at 37 °C,
5% CO2. Cells were differentiated in 1 volume of M199,
4 volumes of DMEM+ 2% foetal bovine serum+ 1 μL/mL
gentamicin.
Cell sorting/immunolabeling
Stocks of primary myogenic cells were purified by mag-
netic activated cell sorting using anti-CD56 (a specific
marker of myoblasts) beads (MACS, Miltenyl Biotech).
Purity before and after cell sorting was determined by
immunolabelling (anti-desmin (1/100, clone D33, Dako)
and anti-mouse IgG1 AlexaFluor 488 (1/400, Life-
Technologies™)). One hundred thousand cells were
plated on a μ-dish 35-mm-high ibidi Treat (ibidi®) in
proliferating medium. After 48 h (approx. 70% conflu-
ence), the cells were washed three times with PBS and
were cultured in DMEM to induce myogenic differenti-
ation. At day 5 of differentiation, cells were fixed and per-
meabilised with 200 μL 95% ethanol at 4 °C overnight,
and blocked with 20% horse serum + 0.1% Triton-X 100 in
PBS, 500 μL, 1 h, RT. Primary antibody anti-desmin (D33,
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IgG1, 1:100, Dako) and secondary antibody goat anti-
mouse IgG1 AlexaFluor 488 (1:400, Invitrogen™) were
used. Culture dishes were washed three times with PBS,
counter-stained with 1 ug/ml DAPI for 1 min, RT, washed
three times with PBS, and mounted with ibidi mounting
medium (ibidi®). Five non-overlapping images were ac-
quired with an Olympus IX70 and an Olympus UPlan FI
10×/0.30 Ph1 objective equipped with a Photomatics
CoolSNAP™ HQ camera. Images were acquired using
Metavue 7.5.6.0 software. The percentage of desmin-
positive cells (desmin to DAPI cells) was calculated.
Sorted cells were found to be of equivalent of higher pur-
ity in each case and subsequently used in cell cultures.
RNA isolation
Cells were plated in four sets of 400000 in 78.5 cm2 petri
dishes (Falcon) for each cell. Cells were switched to dif-
ferentiation medium after 2 days of proliferation
(approx. 70% confluence). After 9 days of differentiation,
cells were scraped and collected in PBS (100 uL). Cells
were centrifuged at 13000 rpm for 10 min, and PBS
supernatant removed. Each pellet was dissolved in TRI-
zol (1 mL). The RNA was subsequently isolated (Pure-
Link RNA Mini Kit, using TRIzol® Reagent with the
PureLink® RNA Mini Kit section of the standard proto-
col) with the RNA eluted in 30 μL H2O.
RNA quality control
RNA quality and purity were determined using the
Nanodrop 2000 (Thermo Scientific, nucleic acid setting)
followed by quality control analysis (Agilent 2100 Bioa-
nalyzer, Eukaryote Total RNA Nano assay, Agilent RNA
6000 Nano Kit, Agilent RNA Nano LabChip) to deter-
mine the RNA integrity number (RIN, 28S/18S ratio).
Gene expression profiling
An aliquot of 150 ng of high-quality total RNA from
each sample was used for mRNA expression profiling.
Samples were analyzed using Illumina® Gene Expression
BeadChip Array technology (Illumina, Inc., San Diego,
CA). Reverse transcription for synthesis of the cDNA
strand, followed by a single in vitro transcription (IVT)
amplification, that incorporates biotin-labeled nucleotides,
were performed with Illumina® TotalPrep™ -96 RNA
Amplification Kit (Ambion, Austin, TX). 750 ng of the
biotin-labeled IVT product (cRNA) was hybridized to
HumanHT-12v4_BeadChip (Illumina, Inc., San Diego,
CA) for 16 h, followed by washing, blocking, and
streptavidin-Cy3 staining according to the Whole Genome
Gene Expression Direct Hybridization protocol (Illumina,
Inc., San Diego, CA). The arrays were scanned using
HiScanSQ System and obtained decoded images were
analyzed by GenomeStudio™ Gene Expression Module—
an integrated platform for the data visualization and ana-
lysis (Illumina, Inc., San Diego, CA).
Transcriptomic raw data treatment
Raw intensity values (Illumina idat files) of 94 samples
were passed to the R lumidat library (https://github.com/
drmjc/lumidat) to create an EListRaw class object compat-
ible with further downstream analyses in R/Bioconductor.
Two samples were excluded at this stage due to having
zero proportion of expressed probes (all other samples
had more than 40% of probes expressed). The limma li-
brary [39] was then used to carry out neqc normaliza-
tion—this involves background correction followed by
quantile normalization, using negative control probes for
background correction and both negative and positive
controls for normalization [40]. Probes were excluded if:
(1) they had low bead numbers in at least one sample; (2)
they were not expressed (expression p value < 0.01) in at
least 16 arrays; (3) they were annotated as no match or
bad quality according to the Bioconductor illuminaHu-
manv4.db library. This gave a total of 15342 probes for
further analysis. The Bioconductor library arrayQuality-
Metrics was used for quality assessment of the arrays [41].
PCA was applied to the normalized values and visualized
using R’s prcomp and plot functions, and the rgl library
for 3D visualization. The R pheatmap library was used to
produce heatmaps of selected genes. Linear regression for
differential expression analysis was applied using limma
[39]. Samples were grouped according to cell_type (group-
ing samples into myoblasts, myotubes, CD56-neg, and the
C25 outlier), and this parameter was used to create a de-
sign matrix (~0 + cell_type), to which limma fitted a linear
model for the normalized expression values. Limma’s
arrayWeights function was used to weight each sample ac-
cording to its estimated reliability by measuring how well
the expression values for that array followed the linear
model [42], limma’s duplicateCorrelation function was
used to estimate the correlation between technical repli-
cates (samples from the same subject, cell type, and clonal
state, were considered as technical replicates) [43], and
limma’s eBayes function was used to rank genes in order
of evidence for differential expression, based on an empir-
ical Bayes method [44].
The data are deposited in NCBI’s Gene Expression
Omnibus and are accessible through GEO series acces-
sion number GSE79263.
Functional analyses of transcriptomic data
Rank-based gene set enrichment tests were carried out
using GSEA [45] on the 15342 quality-filtered, normal-
ized, non-log2, gene expression values described above,
applying default settings (e.g., permutations on pheno-
type, collapse genes to max of probesets) except that
minimum overlap with gene sets was changed from 15
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to 8 to allow for the small sizes of some muscle gene
sets. Gene sets were taken from the muscle gene sets
homepage (Muscle Gene Sets v2) http://sys-myo.rh-
cloud.com/muscle_gene_sets.php or from the Molecular
Signatures Database (http://software.broadinstitute.org/
gsea/msigdb) [45]. Gene set enrichment mapping was
generated using Cytoscape [46] and Enrichment Map
[47]. Enrichment tests were carried out on the most dif-
ferentially expressed 800 genes by fold-change after fil-
tering for FDR < 0.05, using Enrichr [48]. Heatmaps
were created using the pheatmap R function (Raivo
Kolde, 2015).
For the consensus set of genes that were differentially
expressed in previously published studies of myoblast
differentiation, we downloaded publicly available gene
expression data from the Gene Expression Omnibus
(GEO; http://www.ncbi.nlm.nih.gov/geo) database. Four
studies were chosen that included murine and human
myoblasts and myotubes at five or more days of
differentiation: GEO series GSE10424, GSE11415,
GSE24811, and GSE26145. For each study, signals were
converted to expression levels using robust multi-array
averaging [49] and custom chip definition files based on
Entrez genes from the BrainArray resource [50] at http://
brainarray.mbni.med.umich.edu (mgu74av2mmentrezgcdf
17.1.0 for GSE10424, mouse4302mmentrezgcdf 17.1.0
for GSE11415, mogene10stmmentrezgcdf 17.1.0 for
GSE24811 and huex10stv2hsrefseqcdf 17.1.0 for
GSE26145). Specifically, raw CEL files were downloaded
and fluorescence signals were background adjusted,
normalized using quantile normalisation and log2
expression values were calculated using median polish
summarization. To identify differentially expressed genes
for each study, the gene expression matrices were
analysed with statistical analysis of microarray method
(SAM) [51]. For each comparison, a two-class procedure
was applied, and the percentage false discovery rate
(FDR) was calculated. The FDR threshold was set to
0.05, and the 300 most upregulated genes in both groups
in the comparison were selected for further analyses. All
data analyses were performed using R program version
3.0.1, Bioconductor 2.12 libraries, and R statistical
packages.
Assay of Akt pathway activity and microtubule stability
Primary and immortalized myoblasts of lines C25 and
DMD8036 were differentiated for 9 days as described
above.
For Akt pathway activity, proteins were extracted in
RIPA buffer containing phosphatase inhibitors. 15 μg of
protein lysates were separated on 4–12% Bis-Tris gels,
then transferred onto PVDF membrane (overnight, 4 °C,
15 V). After blocking the membrane for 1 h at RT with
5% milk diluted in TBS-Tween, membrane was
incubated with primary antibodies from the Phospho-
Akt Pathway Antibody Sampler Kit (Cell Signalling
Technology) at 1:1000 dilution: Phospho-Akt (Ser473),
Akt (pan), Phospho-c-Raf (Ser259), Phospho-GSK-3β
(Ser9), Phospho-PTEN (Ser380), Phospho-PDK1
(Ser241), and Phospho-Akt (Thr308). Each of these is
phospho-specific except Akt (pan) which targets all Akt
protein independent of its phosphorylation state. Sec-
ondary antibody was anti-rabbit IgG (1:2000 dilution),
HRP-linked. Bands were detected by SuperSignal™ West
Pico Chemiluminescent Substrate (Thermo Fisher) and
X-ray film. C25 and DMD8036 films received 10 and 2-
minute exposures, respectively, and were scanned using
a Xerox Colorqube 9303.
For microtubule stability, cells were cultured in duplicate
dishes, and cDNA was synthesized from RNA using Tran-
scriptor First Strand cDNA Synthesis Kit (Roche), and
amplified by SYBR qPCR synthesis: denaturation 95 °C
8 min; amplification (50 cycles) 95 °C for 15 s, 52 °C for
25 s, 72 °C for 15 s; Tm (for melting curve) 95 °C for 5 s,
40 °C for 30 s then gradually up to 95 °C; cooling 40 °C
for 30 s. Product was separated on 2% agarose gel with
EtBr and detected by UV light.
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